The Obama administration recently stressed the importance of increasing coverage of HIV treatment, as well as increasing access to HIV testing and counseling. It's an initiative that Walgreens, with more than 700 HIV-specialized pharmacies and over 2,000 pharmacists with special HIV/AIDS-accredited educational training, follows closely. Walgreens' senior manager for HIV/AIDS and hepatitis pharmacy services Glen Pietrandoni talked with DSN on the scope of Walgreens' HIV/AIDS services.

The Illinois Lottery will use the net proceeds from a new game to promote HIV/AIDS education, prevention and support, the agency said Wednesday.

The Food and Drug Administration declined to approve two drugs for HIV made by Gilead Sciences for which the company was seeking approval for use as part of treatment regimens.

Anthem Blue Cross will indefinitely suspend a policy that would require many specialty pharmacy patients in California, most of them HIV patients, to receive their drugs via mail order in order to receive coverage for them, drawing criticism from patients and retail pharmacies.

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

Nutra Pharma will introduce a stronger version of its OTC pain reliever, the company said Wednesday.

Thousands of patients in Los Angeles with serious, chronic diseases could soon find themselves unable to get their drugs from community pharmacies, advocates for the pharmacies said.

Drug companies have made "remarkable progress" in treatment options for patients with HIV and AIDS, according to two new reports from a drug industry trade group.

Sanofi Pasteur announced Monday the presentation of three clinical trials of an experimental influenza vaccine.

Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


While the growth in healthcare costs remains a threat in the United States, the growth in drug expenditures is moderating, but numerous opportunities exist for retail, according to a speech delivered Tuesday morning at the National Association of Chain Drug Stores' 2012 Pharmacy and Technology Conference in Denver by Doug Long, VP industry relations of healthcare industry research firm IMS Health.

The largest nonprofit organization focused on HIV and AIDS has acquired a group of specialty pharmacies.